SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST

NCT02924714 · clinicaltrials.gov ↗
NA
Phase
SUSPENDED
Status
31
Enrollment
OTHER
Sponsor class

Stopped Slow accrual

Conditions

Interventions

Sponsor

Oslo University Hospital